For: | Zhou YN, Xu CP, Han B, Li M, Qiao L, Fang DC, Yang JM. Expression of E-cadherin and β-catenin in gastric carcinoma and its correlation with the clinicopathological features and patient survival. World J Gastroenterol 2002; 8(6): 987-993 [PMID: 12439911 DOI: 10.3748/wjg.v8.i6.987] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v8/i6/987.htm |
Number | Citing Articles |
1 |
Yoshimi Arima, Yasumichi Inoue, Tatsuhiro Shibata, Hidemi Hayashi, Osamu Nagano, Hideyuki Saya, Yoichi Taya. Rb Depletion Results in Deregulation of E-Cadherin and Induction of Cellular Phenotypic Changes that Are Characteristic of the Epithelial-to-Mesenchymal Transition. Cancer Research 2008; 68(13): 5104 doi: 10.1158/0008-5472.CAN-07-5680
|
2 |
Tiannan Guo, Sze Sing Lee, Wai Har Ng, Yi Zhu, Chee Sian Gan, Jiang Zhu, Haixia Wang, Shiang Huang, Siu Kwan Sze, Oi Lian Kon. Global molecular dysfunctions in gastric cancer revealed by an integrated analysis of the phosphoproteome and transcriptome. Cellular and Molecular Life Sciences 2011; 68(11): 1983 doi: 10.1007/s00018-010-0545-x
|
3 |
Amirhossein Davoodvandi, Marjan Farshadi, Noushid Zare, Seyed Amirreza Akhlagh, Esmail Alipour Nosrani, Maryam Mahjoubin-Tehran, Parisa Kangari, Seyedeh Maryam Sharafi, Haroon Khan, Michael Aschner, Ghazaleh Baniebrahimi, Hamed Mirzaei. Antimetastatic Effects of Curcumin in Oral and Gastrointestinal Cancers. Frontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.668567
|
4 |
Florian Lordick, Tobias Schulze, Dirk Jäger. The role of biologics in stomach cancer. Targeted Oncology 2008; 3(2): 71 doi: 10.1007/s11523-008-0078-5
|
5 |
Nick Baniak, Jenna-Lynn Senger, Shahid Ahmed, S. C. Kanthan, Rani Kanthan. Gastric biomarkers: a global review. World Journal of Surgical Oncology 2016; 14(1) doi: 10.1186/s12957-016-0969-3
|
6 |
Minjeong Jang, Ilkyoo Koh, Jae Eun Lee, Ju Yeon Lim, Jae-Ho Cheong, Pilnam Kim. Increased extracellular matrix density disrupts E-cadherin/β-catenin complex in gastric cancer cells. Biomaterials Science 2018; 6(10): 2704 doi: 10.1039/C8BM00843D
|
7 |
Manoj Kumar Gupta, Jinka Rajeswari, Pamuru Ramachandra Reddy, Koppula Satish Kumar, K. V. Chamundeswaramma, Ramakrishna Vadde. Recent Advancements in Biomarkers and Early Detection of Gastrointestinal Cancers. Diagnostics and Therapeutic Advances in GI Malignancies 2020; : 191 doi: 10.1007/978-981-15-4431-6_11
|
8 |
Hai-Ling Wang, Xue-Ke Zhao, Fu-You Zhou, Xin Song, Liu-Yu Li, Gai-Rong Huang, Qi-De Bao, Ling-Ling Lei, Hai-Jun Yang, Li Li, Rui-Hua Xu, Ai-Li Li, Xian-Zeng Wang, Wen-Li Han, Jing-Li Ren, Li-Dong Wang. Characterization of E-cadherin expression in normal mucosa, dysplasia and adenocarcinoma of gastric cardia and its influence on prognosis. World Journal of Gastrointestinal Oncology 2022; 14(1): 265-277 doi: 10.4251/wjgo.v14.i1.265
|
9 |
Kai-Lin Cai, Guo-Bing Wang, Li-Juan Xiong. Effects of carbon dioxide and nitrogen on adhesive growth and expressions of E-cadherin and VEGF of human colon cancer cell CCL-228. World Journal of Gastroenterology 2003; 9(7): 1594-1597 doi: 10.3748/wjg.v9.i7.1594
|
10 |
R Selvi, Sattar Mohammed Sarnam, S. Kayalvizhi, P Venkatachalam, A. Rekha, R. Selvaraj, Shanthi Vijayaraghavan. Altered regulation of Ure A and β-catenin gene expression levels in Helicobacter pylori-associated chronic gastritis. Indian Journal of Applied Microbiology 2017; 20(02): 74 doi: 10.46798/ijam.2017.v20i02.006
|
11 |
Hala S.E. Alaa Edin, Salah M. El Sayed, Rafaat A. Bakheet, Amal N.A. Allithy. E-cadherin immunohistochemical expression in gastric carcinoma in relation to different clinicopathological parameters. Egyptian Journal of Pathology 2021; 41(1): 98 doi: 10.4103/egjp.egjp_39_21
|
12 |
Xiaowen Liu, Ziwen Long, Hong Cai, Shengjia Yu, Jianghong Wu. TRIM58 suppresses the tumor growth in gastric cancer by inactivation of β-catenin signaling via ubiquitination. Cancer Biology & Therapy 2020; 21(3): 203 doi: 10.1080/15384047.2019.1679554
|
13 |
Haruo Iguchi. Recent aspects for disseminated carcinomatosis of the bone marrow associated with gastric cancer: What has been done for the past, and what will be needed in future?. World Journal of Gastroenterology 2015; 21(43): 12249-12260 doi: 10.3748/wjg.v21.i43.12249
|
14 |
Abeer A. Saad, Nahla M. Awed, Nashwa N. A. Abd Elkerim, Dina EL-Shennawy, Marian A. Alfons, Mohamed E. Elserafy, Yaser W. Darwish, Eman M. F. Barakat, Sahar S. Ezz-Elarab. Prognostic Significance of E-cadherin Expression and Peripheral Blood Micrometastasis in Gastric Carcinoma Patients. Annals of Surgical Oncology 2010; 17(11): 3059 doi: 10.1245/s10434-010-1151-8
|
15 |
In Mok Jung, Jung Kee Chung, Young A Kim, Je Eun Kim, Seung Chul Heo, Young Joon Ahn, Ki-Tae Hwang, Byeong Gwan Kim, Kook Lae Lee, Chul Woo Kim, Woo Ho Kim, Mee Soo Chang. Epstein-Barr Virus, Beta-Catenin, and E-cadherin in Gastric Carcinomas. Journal of Korean Medical Science 2007; 22(5): 855 doi: 10.3346/jkms.2007.22.5.855
|
16 |
Ralph Carvalho, Anya NA Milne, Bastiaan P van Rees, Eric Caspers, Luís Cirnes, Céu Figueiredo, G Johan A Offerhaus, Marian AJ Weterman. Early‐onset gastric carcinomas display molecular characteristics distinct from gastric carcinomas occurring at a later age. The Journal of Pathology 2004; 204(1): 75 doi: 10.1002/path.1602
|
17 |
Xiaolan You, Yuanjie Wang, Jian Wu, Qinghong Liu, Dehu Chen, Dong Tang, Daorong Wang. Aberrant Cytokeratin 20 mRNA Expression in Peripheral Blood and Lymph Nodes Indicates Micrometastasis and Poor Prognosis in Patients With Gastric Carcinoma. Technology in Cancer Research & Treatment 2019; 18 doi: 10.1177/1533033819832856
|
18 |
Ji Hoon Kim, Dae Yoon Eom, Chan Wook Kim, Nam Kyu Choi, Jin Ho Kwak, Gun Moo Choi, Hyuck Jae Jang, Myung Sik Han. Expression of E-cadherin, β-catenin, Cdx2 and MMP7 in pT2 and N1/N2 Gastric Cancer: Relationship with Tumor Recurrence within 2-Year Period. Journal of the Korean Surgical Society 2011; 80(1): 29 doi: 10.4174/jkss.2011.80.1.29
|
19 |
Sung-Soo Park, Sang-Hee Kang, Joong-Min Park, Jong-Han Kim, Sang-Cheul Oh, Ju-Han Lee, Yang-Seok Chae, Seung-Joo Kim, Chong-Suk Kim, Young-Jae Mok. Expression of Liver–Intestine Cadherin and Its Correlation with Lymph Node Metastasis in Gastric Cancer: Can It Predict N Stage Preoperatively?. Annals of Surgical Oncology 2006; 14(1): 94 doi: 10.1245/s10434-006-9114-9
|
20 |
Birgit Luber, Armando Gamboa-Dominguez, Karl-Friedrich Becker, Falko Fend, Heinz Höfler. Molecular Genetics, Gastrointestinal Carcinoma, and Ovarian Carcinoma. Handbook of Immunohistochemistry and in Situ Hybridization of Human Carcinomas 2005; 4: 169 doi: 10.1016/S1874-5784(05)80073-X
|
21 |
Bomi Kim, Sun-Ju Byun, Young A. Kim, Ji Eun Kim, Byung Lan Lee, Woo Ho Kim, Mee Soo Chang. Cell cycle regulators, APC/β-catenin, NF-κB and Epstein-Barr virus in gastric carcinomas. Pathology 2010; 42(1): 58 doi: 10.3109/00313020903356392
|
22 |
Ihab Abdulkader, José Cameselle-Teijeiro, Jerónimo Forteza. Signet-ring cells associated with pseudomembranous colitis. Virchows Archiv 2003; 442(4): 412 doi: 10.1007/s00428-003-0779-1
|
23 |
Chi-Chen Fan, Tao-Yeuan Wang, Yen-An Cheng, Shih Sheng Jiang, Chien-Wen Cheng, Alan Yueh-Luen Lee, Ting-Yu Kao. Expression of E-cadherin, Twist, and p53 and their prognostic value in patients with oral squamous cell carcinoma. Journal of Cancer Research and Clinical Oncology 2013; 139(10): 1735 doi: 10.1007/s00432-013-1499-9
|
24 |
Elena Lastraioli, Maria Raffaella Romoli, Annarosa Arcangeli. Immunohistochemical Biomarkers in Gastric Cancer Research and Management. International Journal of Surgical Oncology 2012; 2012: 1 doi: 10.1155/2012/868645
|
25 |
Yihong R. Ma, Zhiyong Ren, Michael G. Conner, Gene P. Siegal, Shi Wei. Reduced E-Cadherin and Aberrant β-Catenin Expression are Associated With Advanced Disease in Signet-Ring Cell Carcinomas. Applied Immunohistochemistry & Molecular Morphology 2017; 25(6): 432 doi: 10.1097/PAI.0000000000000317
|
26 |
Xi-Mei Chen, Guo-Yu Chen, Zhi-Rong Wang, Feng-Shang Zhu, Xiao-Lei Wang, Xia Zhang. Detection of micrometastasis of gastric carcinoma in peripheral blood circulation. World Journal of Gastroenterology 2004; 10(6): 804-808 doi: 10.3748/wjg.v10.i6.804
|
27 |
Pallaval Veera Bramhachari, Nageswara Rao Reddy Neelapu. Recent Advancements in Biomarkers and Early Detection of Gastrointestinal Cancers. Diagnostics and Therapeutic Advances in GI Malignancies 2020; : 3 doi: 10.1007/978-981-15-4431-6_1
|
28 |
Guo-yang Sun, Jun-xia Wu, Jian-sheng Wu, Yu-ting Pan, Rong Jin. Caveolin-1, E-cadherin and β-catenin in gastric carcinoma, precancerous tissues and chronic non-atrophic gastritis. Chinese Journal of Cancer Research 2012; 24(1): 23 doi: 10.1007/s11670-012-0023-0
|
29 |
K A Voutilainen, M A Anttila, S M Sillanpää, K M Ropponen, S V Saarikoski, M T Juhola, V-M Kosma. Prognostic significance of E-cadherin–catenin complex in epithelial ovarian cancer. Journal of Clinical Pathology 2006; 59(5): 460 doi: 10.1136/jcp.2005.029876
|
30 |
EIJI IWATA, TAKUMI HASEGAWA, DAISUKE TAKEDA, TAKESHI UEHA, TERUYA KAWAMOTO, TOSHIHIRO AKISUE, YOSHITADA SAKAI, TAKAHIDE KOMORI. Transcutaneous carbon dioxide suppresses epithelial-mesenchymal transition in oral squamous cell carcinoma. International Journal of Oncology 2016; 48(4): 1493 doi: 10.3892/ijo.2016.3380
|
31 |
Amal N. Allithy, Habeeb A. Baig, Anas A. Darwish, Ghadeer A.M. Al-Harbi, Hala S.E. Alaa Edin. Differential E-cadherin expression in helicobacter-related gastric pathology. Egyptian Journal of Pathology 2021; 41(2): 186 doi: 10.4103/egjp.egjp_53_21
|
32 |
Genlin Lu, Zhai Cai, Renya Jiang, Fei Tong, Jinming Tu, Yandong Chen, Yinglan Fu, Jingyi Sun, Tao Zhang. Reduced expression of E-cadherin correlates with poor prognosis and unfavorable clinicopathological features in gastric carcinoma: a meta-analysis. Aging 2024; 16(12): 10271 doi: 10.18632/aging.205929
|
33 |
Stuart J. Netherton, Shirin Bonni, Marc Vooijs. Suppression of TGFβ-Induced Epithelial-Mesenchymal Transition Like Phenotype by a PIAS1 Regulated Sumoylation Pathway in NMuMG Epithelial Cells. PLoS ONE 2010; 5(11): e13971 doi: 10.1371/journal.pone.0013971
|
34 |
E. Bria, G. De Manzoni, S. Beghelli, A. Tomezzoli, S. Barbi, C. Di Gregorio, M. Scardoni, E. Amato, M. Frizziero, I. Sperduti, V. Corbo, M. Brunelli, S. Bersani, G. Tortora, A. Scarpa. A clinical–biological risk stratification model for resected gastric cancer: prognostic impact of Her2, Fhit, and APC expression status. Annals of Oncology 2013; 24(3): 693 doi: 10.1093/annonc/mds506
|
35 |
|
36 |
Armando Gamboa-Dominguez, Claudia Dominguez-Fonseca, Yanin Chavarri-Guerra, Roberto Vargas, Edgardo Reyes-Gutierrez, Dan Green, Leticia Quintanilla-Martinez, Birgit Luber, Raymonde Busch, Karl-Friedrich Becker, Ingrid Becker, Heinz Höfler, Falko Fend. E-Cadherin expression in Sporadic Gastric cancer from Mexico: Exon 8 and 9 deletions are infrequent events associated with poor survival. Human Pathology 2005; 36(1): 29 doi: 10.1016/j.humpath.2004.09.020
|
37 |
Jung Hwan Yoon, Jung Woo Eun, Won Suk Choi, Olga Kim, Suk Woo Nam, Jung Young Lee, Won Sang Park. NKX6.3 Is a Transcription Factor for Wnt/β-catenin and Rho-GTPase Signaling-Related Genes to Suppress Gastric Cancer Progression. EBioMedicine 2016; 9: 97 doi: 10.1016/j.ebiom.2016.05.027
|
38 |
Jason J. Christiansen, Ayyappan K. Rajasekaran. Reassessing Epithelial to Mesenchymal Transition as a Prerequisite for Carcinoma Invasion and Metastasis. Cancer Research 2006; 66(17): 8319 doi: 10.1158/0008-5472.CAN-06-0410
|
39 |
B‐J Lü, M Lai, L Cheng, J‐Y Xu, Q Huang. Gastric medullary carcinoma, a distinct entity associated with microsatellite instability‐H, prominent intraepithelial lymphocytes and improved prognosis. Histopathology 2004; 45(5): 485 doi: 10.1111/j.1365-2559.2004.01998.x
|
40 |
Alan Yueh-Luen Lee, Chi-Chen Fan, Yen-An Chen, Chieh-Wen Cheng, Ya-Ju Sung, Chih-Ping Hsu, Ting-Yu Kao. Curcumin Inhibits Invasiveness and Epithelial-Mesenchymal Transition in Oral Squamous Cell Carcinoma Through Reducing Matrix Metalloproteinase 2, 9 and Modulating p53-E-Cadherin Pathway. Integrative Cancer Therapies 2015; 14(5): 484 doi: 10.1177/1534735415588930
|
41 |
Hua-Chuan Zheng, Jin-Min Sun, Zheng-Li Wei, Xue-Fei Yang, Yin-Chang Zhang, Yan Xin. Expression of Fas ligand and Caspase-3 contributes to formation of immune escape in gastric cancer. World Journal of Gastroenterology 2003; 9(7): 1415-1420 doi: 10.3748/wjg.v9.i7.1415
|
42 |
Peng Lee, Shilpa Jain, Matthew R. Pincus, Ruliang Xu. Henry's Clinical Diagnosis and Management by Laboratory Methods. 2011; : 1441 doi: 10.1016/B978-1-4377-0974-2.00076-2
|
43 |
Edaise M. Silva, Maria D. Begnami, José Humberto T. G. Fregnani, Adriane G. Pelosof, Claudia Zitron, André L. Montagnini, Fernando Augusto Soares. Cadherin-catenin adhesion system and mucin expression: a comparison between young and older patients with gastric carcinoma. Gastric Cancer 2008; 11(3): 149 doi: 10.1007/s10120-008-0468-5
|
44 |
Donald Earl Henson, Christopher Dittus, Mamoun Younes, Hong Nguyen, Jorge Albores-Saavedra. Differential Trends in the Intestinal and Diffuse Types of Gastric Carcinoma in the United States, 1973–2000: Increase in the Signet Ring Cell Type. Archives of Pathology & Laboratory Medicine 2004; 128(7): 765 doi: 10.5858/2004-128-765-DTITIA
|
45 |
Claus Wilhelm Schildberg, Mohammed Abba, Susanne Merkel, Abbas Agaimy, Arno Dimmler, Anne Schlabrakowski, Roland Croner, Jörg Hendrik Leupold, Werner Hohenberger, Heike Allgayer. Gastric cancer patients less than 50 years of age exhibit significant downregulation of E-cadherin and CDX2 compared to older reference populations. Advances in Medical Sciences 2014; 59(1): 142 doi: 10.1016/j.advms.2014.03.002
|
46 |
Zhe-Yi Han, Kai-Chun Wu, Feng-Tian He, Quan-Li Han, Yong-Zhan Nie, Ying Han, Xiao-Nan Liu, Jian-Yong Zheng, Mei-Hong Xu, Tao Lin, Dai-Ming Fan. Screening and identification of mimotope of gastric cancer associated antigen MGb1-Ag. World Journal of Gastroenterology 2003; 9(9): 1920-1924 doi: 10.3748/wjg.v9.i9.1920
|
47 |
Ji Yeong An, Tae Ho Kang, Min Gew Choi, Jae Hyung Noh, Tae Sung Sohn, Sung Kim. Borrmann Type IV: An Independent Prognostic Factor for Survival in Gastric Cancer. Journal of Gastrointestinal Surgery 2008; 12(8): 1364 doi: 10.1007/s11605-008-0516-9
|
48 |
Puneet Kumar, Arun Sebastian, Khushi Verma, Ruhi Dixit, Soni Kumari, Juhi Singh, Satyendra Kumar Tiwary, Gopeshwar Narayan. mRNA Expression Analysis of E-Cadherin, VEGF, and MMPs in Gastric Cancer: a Pilot Study. Indian Journal of Surgical Oncology 2021; 12(S1): 85 doi: 10.1007/s13193-020-01096-5
|
49 |
Takahito Kamikihara, Sumiya Ishigami, Takaaki Arigami, Masataka Matsumoto, Hiroshi Okumura, Yasuto Uchikado, Yoshiaki Kita, Hiroshi Kurahara, Yuko Kijima, Shinichi Ueno, Shoji Natsugoe. Clinical implications of N‐cadherin expression in gastric cancer. Pathology International 2012; 62(3): 161 doi: 10.1111/j.1440-1827.2011.02774.x
|
50 |
Elizabeth G Demicco, Alton B Farris, Yoshifumi Baba, Brian Agbor-Etang, Kristin Bergethon, Rajni Mandal, Diane Daives, Junya Fukuoka, Michio Shimizu, Dora Dias-Santagata, Shuji Ogino, A John Iafrate, Henning A Gaissert, Mari Mino-Kenudson. The dichotomy in carcinogenesis of the distal esophagus and esophagogastric junction: intestinal-type vs cardiac-type mucosa-associated adenocarcinoma. Modern Pathology 2011; 24(9): 1177 doi: 10.1038/modpathol.2011.77
|
51 |
VICTORIA HAHN‐STRÖMBERG, HENRIK EDVARDSSON, LENNART BODIN, LENNART FRANZÉN. Disturbed expression of E‐cadherin, beta‐catenin and tight junction proteins in colon carcinoma is unrelated to growth pattern and genetic polymorphisms. APMIS 2008; 116(4): 253 doi: 10.1111/j.1600-0463.2008.00894.x
|
52 |
Yunzhan Zhang, Danyan Li, Yunkai Dai, Ruliu Li, Yong Gao, Ling Hu. The Role of E-cadherin in Helicobacter pylori-Related Gastric Diseases. Current Drug Metabolism 2019; 20(1): 23 doi: 10.2174/1389200219666180625113010
|
53 |
Meng-Chun Wang, Yan-Min Yang, Xiao-Han Li, Fang Dong, Yan Li. Maspin expression and its clinicopathological significance in tumorigenesis and progression of gastric cancer. World Journal of Gastroenterology 2004; 10(5): 634-637 doi: 10.3748/wjg.v10.i5.634
|
54 |
Yihong R Ma, Gene P Siegal, Shi Wei. Reacquisition of E-cadherin expression in metastatic deposits of signet-ring cell carcinoma of the upper gastrointestinal system: a potential anchor for metastatic deposition. Journal of Clinical Pathology 2017; 70(6): 528 doi: 10.1136/jclinpath-2016-203959
|
55 |
Christopher Udayan C, Prabhalakshmy K. K, Sankar S. E-CADHERIN EXPRESSION IN GASTRIC ADENOCARCINOMA. Journal of Evolution of Medical and Dental Sciences 2018; 7(13): 1630 doi: 10.14260/jemds/2018/369
|
56 |
Dong Ye, Gaosheng Xu, Wei Ma, Yuxuan Li, Weiru Luo, Yiyang Xiao, Yong Liu, Zhiwei Zhang. Significant function and research progress of biomarkers in gastric cancer (Review). Oncology Letters 2019; doi: 10.3892/ol.2019.11078
|
57 |
H. Doucas, G. Garcea, C.P. Neal, M.M. Manson, D.P. Berry. Changes in the Wnt signalling pathway in gastrointestinal cancers and their prognostic significance. European Journal of Cancer 2005; 41(3): 365 doi: 10.1016/j.ejca.2004.11.005
|
58 |
Lionel Lim, Michael Michael, G. Bruce Mann, Trevor Leong. Adjuvant Therapy in Gastric Cancer. Journal of Clinical Oncology 2005; 23(25): 6220 doi: 10.1200/JCO.2005.11.593
|
59 |
Margaret Cho, Ogechukwu Eze, Ruliang Xu. Molecular genetics of gastric adenocarcinoma in clinical practice. World Journal of Medical Genetics 2014; 4(3): 58-68 doi: 10.5496/wjmg.v4.i3.58
|
60 |
Robab Anbiaee, Khosrow Mojir Sheibani, Peyman Torbati, Hanieh Jaam. Abnormal Expression of E-Cadherin in Gastric Adenocarcinoma, and Its Correlation With Tumor Histopathology and Helicobacter Pylori Infection. Iranian Red Crescent Medical Journal 2013; 15(3): 218 doi: 10.5812/ircmj.4032
|
61 |
Hongyi Zhu, Yuanwen Chen, Jie Zhang, Changlin Qian, Weiqing Qiu, Huojian Shen, Zhiyong Shen. <p>Knockdown of TRIM37 Promotes Apoptosis and Suppresses Tumor Growth in Gastric Cancer by Inactivation of the ERK1/2 Pathway</p>. OncoTargets and Therapy 2020; : 5479 doi: 10.2147/OTT.S233906
|
62 |
Ying-Chieh Lai, Ta-Sen Yeh, Ren-Chin Wu, Cheng-Kun Tsai, Lan-Yan Yang, Gigin Lin, Michael D. Kuo. Acute Tumor Transition Angle on Computed Tomography Predicts Chromosomal Instability Status of Primary Gastric Cancer: Radiogenomics Analysis from TCGA and Independent Validation. Cancers 2019; 11(5): 641 doi: 10.3390/cancers11050641
|
63 |
P R Almeida, V A Ferreira, C C Santos, F D Rocha-Filho, R R Feitosa, E A A Falcão, B K Cavada, R A Ribeiro. E-cadherin immunoexpression patterns in the characterisation of gastric carcinoma histotypes. Journal of Clinical Pathology 2010; 63(7): 635 doi: 10.1136/jcp.2010.076026
|
64 |
Chao Yan, Zheng-Gang Zhu, Ying-Yan Yu, Jun Ji, Yi Zhang, Yu-Bao Ji, Min Yan, Jun Chen, Bing-Ya Liu, Hao-Ran Yin, Yan-Zhen Lin. Expression of vascular endothelial growth factor C and chemokine receptor CCR7 in gastric carcinoma and their values in predicting lymph node metastasis. World Journal of Gastroenterology 2004; 10(6): 783-790 doi: 10.3748/wjg.v10.i6.783
|
65 |
Xiu-wen Yu, Qian Xu, Yue-hua Gong, Nan-nan Dong, Yuan Yuan. Detection in situ of E-cadherin, β-catenin, TCF4 and CDX2 in various gastric diseases. Chinese Journal of Cancer Research 2009; 21(3): 185 doi: 10.1007/s11670-009-0185-6
|
66 |
Jolanta Czyzewska, Katarzyna Guzińska-Ustymowicz, Marek Ustymowicz, Anna Pryczynicz, Andrzej Kemona. The expression of E-cadherin-catenin complex in patients with advanced gastric cancer: role in formation of metastasis.. Folia Histochemica et Cytobiologica 2010; 48(1) doi: 10.2478/v10042-010-0017-z
|
67 |
Dorra Ben Ayed-Guerfali, Basma Hassairi, Abdelmajid Khabir, Tahia Sellami-Boudawara, Ali Gargouri, Raja Mokdad-Gargouri. Expression of APC, β-catenin and E-cadherin in Tunisian patients with gastric adenocarcinoma: clinical significance. Tumor Biology 2014; 35(3): 1775 doi: 10.1007/s13277-013-1236-7
|
68 |
Yosuke Seki, Hirofumi Yamamoto, Chew Yee Ngan, Masayoshi Yasui, Naruya Tomita, Kotaro Kitani, Ichiro Takemasa, Masataka Ikeda, Mitsugu Sekimoto, Nariaki Matsuura, Chris Albanese, Yasufumi Kaneda, Richard G. Pestell, Morito Monden. Construction of a novel DNA decoy that inhibits the oncogenic β-catenin/T-cell factor pathway. Molecular Cancer Therapeutics 2006; 5(4): 985 doi: 10.1158/1535-7163.MCT-05-0388
|
69 |
A. V. Shulha, V. A. Basinsky, S. A. Lalikov, S. E. Savitsky. Immunohistohemical ASSESSMENT of E-cadherin expression AT ovarian cancer. Health and Ecology Issues 2009; (1): 58 doi: 10.51523/2708-6011.2009-6-1-11
|
70 |
Eriko Takeyama, Mio Tanaka, Jun Fujishiro, Norihiko Kitagawa, Tadashi Iwanaka, Yukichi Tanaka. A case of alpha-fetoprotein-producing gastric cancer in a child presenting with rupture of multiple liver metastases. Pediatric Surgery International 2015; 31(9): 885 doi: 10.1007/s00383-015-3724-x
|
71 |
Wen-Hui Lien, Valeri Vasioukhin. Cancer Genome and Tumor Microenvironment. 2010; : 33 doi: 10.1007/978-1-4419-0711-0_3
|
72 |
Li-Fu Li, Zheng-Jie Wei, Hong Sun, Bo Jiang. Abnormal β-catenin immunohistochemical expression as a prognostic factor in gastric cancer: A meta-analysis. World Journal of Gastroenterology 2014; 20(34): 12313-12321 doi: 10.3748/wjg.v20.i34.12313
|
73 |
Katie Palen, James Weber, Michael B. Dwinell, Bryon D. Johnson, Ramani Ramchandran, Jill A. Gershan. E-cadherin re-expression showsin vivoevidence for mesenchymal to epithelial transition in clonal metastatic breast tumor cells. Oncotarget 2016; 7(28): 43363 doi: 10.18632/oncotarget.9715
|
74 |
Ammar Natalwala, Robert Spychal, Chris Tselepis. Epithelial-mesenchymal transition mediated tumourigenesis in the gastrointestinal tract. World Journal of Gastroenterology 2008; 14(24): 3792-3797 doi: 10.3748/wjg.14.3792
|
75 |
A.A. Abd El-Rahman, Emad S. Mishriki, Amal A. Shehab, A.A. Mona. Therapeutic effect of pentoxifylline versus losartan on experimentally induced acute pancreatitis in adult albino rats. The Egyptian Journal of Histology 2011; 34(3): 606 doi: 10.1097/01.EHX.0000401367.91216.9d
|
76 |
Katarzyna Karpińska-Kaczmarczyk, Magdalena Lewandowska, Małgorzata Ławniczak, Andrzej Białek, Elżbieta Urasińska. Expression of Mismatch Repair Proteins in Early and Advanced Gastric Cancer in Poland. Medical Science Monitor 2016; 22: 2886 doi: 10.12659/MSM.897150
|
77 |
Hai-Dan Wang, Jun Ren, Lian Zhang. CDH1 germline mutation in hereditary gastric carcinoma. World Journal of Gastroenterology 2004; 10(21): 3088-3093 doi: 10.3748/wjg.v10.i21.3088
|
78 |
Masakazu Yashiro, Nobuaki Nishioka, Kosei Hirakawa. Decreased expression of the adhesion molecule desmoglein-2 is associated with diffuse-type gastric carcinoma. European Journal of Cancer 2006; 42(14): 2397 doi: 10.1016/j.ejca.2006.03.024
|
79 |
Futao Hou, Weijie Yuan, Jin Huang, Liyuan Qian, Zhikang Chen, Jie Ge, Shaobin Wu, Jinxiang Chen, Jixu Wang, Zihua Chen. Overexpression of EphA2 correlates with epithelial–mesenchymal transition-related proteins in gastric cancer and their prognostic importance for postoperative patients. Medical Oncology 2012; 29(4): 2691 doi: 10.1007/s12032-011-0127-2
|
80 |
Mario Scartozzi, Eva Galizia, Federica Freddari, Rossana Berardi, Riccardo Cellerino, Stefano Cascinu. Molecular biology of sporadic gastric cancer: prognostic indicators and novel therapeutic approaches. Cancer Treatment Reviews 2004; 30(5): 451 doi: 10.1016/j.ctrv.2004.01.001
|
81 |
Sang Yong Song, Seonwoo Kim, Dae Shick Kim, Hee Jung Son, Jong Chul Rhee, Yong Il Kim. Abnormal Expression of E-cadherin in Early Gastric Carcinoma. Journal of Clinical Gastroenterology 2004; 38(3): 252 doi: 10.1097/00004836-200403000-00011
|